Compounded Semaglutide with Glycine may be prescribed by a licensed medical provider as part of a medically supervised weight management program. This formulation is prepared by a licensed compounding pharmacy based on a provider’s prescription and individualized patient needs.
Semaglutide is a GLP-1 receptor agonist that acts on pathways involved in appetite regulation and glucose metabolism. When prescribed, compounded Semaglutide may help support appetite control and feelings of fullness as part of a comprehensive care plan that includes medical oversight and lifestyle considerations.
Treatment decisions are made by a licensed provider following a medical evaluation. Individual results may vary, and compounded medications are not reviewed or approved by the FDA.
